Cefuroxime axetil labels and packages
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Abdurahman Khalil, M.D. [2]
Principal Display Panel
NDC 0173-0387-00
Ceftin® Tablets
(cefuroximeaxetil tablets)
250 mg 20 Tablets
Rx only
See package insert for Dosage and Administration.
Store between 15o and 30oC (59o and 86oF).
Replace cap securely after each opening.
GlaxoSmithKline
Research Triangle Park, NC 27709
Made in England
4142817
Rev. 2/02
 |
Principal Display Panel
NDC 0173-0394-00
Ceftin® Tablets
(cefuroximeaxetil tablets)
500 mg
Rx only
20 Tablets
Each tablet contains cefuroxime axetil equivalent to 500 mg of cefuroxime.
See package insert for Dosage and Administration.
Store between 15o and 30oC (59o and 86oF). Replace cap securely after each opening.
GlaxoSmithKline
Research Triangle Park, NC 27709
Made in England
4141667 Rev. 12/01
 |
Principal Display Panel
NDC 0173-0740-00
Ceftin® for Oral Suspension
(cefuroximeaxetil powder for oral suspension)
For Oral Use Only
125 mg per 5 mL
100 mL (when reconstituted)
Rx only
Contains 3.0 g cefuroxime axetil equivalent to 2.5 g of cefuroxime.
Phenylketonurics: Contains Phenylalanine 11.8 mg per 5 mL (1 teaspoonful) constituted suspension.
See package insert for Dosage and Administration.
Directions for Mixing Oral Suspension: Prepare the suspension at time of dispensing. Shake the bottle to loosen the powder. Remove the cap. Add 37 mL of water for reconstitution and replace the cap. Invert bottle and vigorously rock it from side to side so that water rises through the powder. Once the sound of powder against the bottle disappears, turn the bottle upright and vigorously shake it in a diagonal direction.
Before reconstitution, store dry powder between 2o and 30oC (36o and 86oF).
After reconstitution, store suspension between 2o and 8oC (36o and 46oF), in a refrigerator. SHAKE WELL BEFORE EACH USE. Replace cap securely after each opening. Discard after 10 days.
GlaxoSmithKline
Research Triangle Park, NC 27709
Made in England
10000000022540 Rev. 12/05
 |
Principal Display Panel
NDC 0173-0741-10
Ceftin® for Oral Suspension
(cefuroximeaxetil powder for oral suspension)
For Oral Use Only
250 mg per 5 mL
50 mL (when reconstituted)
Contains 3.6 g cefuroxime axetil equivalent to 3 g of cefuroxime.
Phenylketonurics: Contains Phenylalanine 25.2 mg per 5 mL (1 teaspoonful) constituted suspension.
See package insert for Dosage and Administration.
Directions for Mixing Oral Suspension: Prepare the suspension at time of dispensing. Shake the bottle to loosen the powder. Remove the cap. Add 19 mL of water for reconstitution and replace the cap. Invert bottle and vigorously rock it from side to side so that water rises through the powder. Once the sound of powder against the bottle disappears, turn the bottle upright and vigorously shake it in a diagonal direction.
Before reconstitution, store dry powder between 2o and 30oC (36o and 86oF).
After reconstitution, store suspension between 2o and 8oC (36o and 46oF), in a refrigerator. SHAKE WELL BEFORE EACH USE. Replace cap securely after each opening. Discard after 10 days.
GlaxoSmithKline
Research Triangle Park, NC 27709
Made in England
10000000022489 Rev. 12/05
 |
References
http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/050605s042lbl.pdf